These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 34151606

  • 1. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
    Malmborg M, Schmiegelow MDS, Gerds T, Schou M, Kistorp C, Torp-Pedersen C, Gislason G.
    J Am Heart Assoc; 2021 Jul 06; 10(13):e020395. PubMed ID: 34151606
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
    Rannanheimo PK, Tiittanen P, Hartikainen J, Helin-Salmivaara A, Huupponen R, Vahtera J, Korhonen MJ.
    Value Health; 2015 Sep 06; 18(6):896-905. PubMed ID: 26409618
    [Abstract] [Full Text] [Related]

  • 4. Statin therapy and cardiovascular protection in type 2 diabetes: The role of baseline LDL-Cholesterol levels. A systematic review and meta-analysis of observational studies.
    Soroush N, Nekouei Shahraki M, Mohammadi Jouabadi S, Amiri M, Aribas E, Stricker BH, Ahmadizar F.
    Nutr Metab Cardiovasc Dis; 2024 Sep 06; 34(9):2021-2033. PubMed ID: 38866619
    [Abstract] [Full Text] [Related]

  • 5. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A, Buda S, Degli Esposti E.
    Clin Ther; 2012 Jan 06; 34(1):190-9. PubMed ID: 22284998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A, Sabbah L, Perdrix L, Blanchard D, Danchin N, Puymirat E.
    Arch Cardiovasc Dis; 2013 Oct 06; 106(10):511-6. PubMed ID: 24080324
    [Abstract] [Full Text] [Related]

  • 8. Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study.
    Zhu L, Hayen A, Bell KJL.
    Cardiovasc Diabetol; 2020 Mar 05; 19(1):28. PubMed ID: 32138746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Verma S, Leiter LA, Mazer CD, Bain SC, Buse J, Marso S, Nauck M, Zinman B, Bosch-Traberg H, Rasmussen S, Michelsen MM, Bhatt DL.
    Circulation; 2018 Oct 09; 138(15):1605-1607. PubMed ID: 30354517
    [No Abstract] [Full Text] [Related]

  • 11. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N, Henrard S, van den Akker M, Goderis G, Buntinx F, Van Pottelbergh G, Vaes B.
    BMC Cardiovasc Disord; 2018 Nov 06; 18(1):209. PubMed ID: 30400778
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
    Desjobert E, Tea V, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E, FAST-MI investigators.
    Arch Cardiovasc Dis; 2021 Feb 06; 114(2):88-95. PubMed ID: 33011156
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Statin diabetogenicity: guidance for clinicians.
    Ray K.
    Cardiovasc Diabetol; 2013 Feb 06; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.